Last reviewed · How we verify
Drug Eluting Bead Transarterial Chemoembolization — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Drug Eluting Bead Transarterial Chemoembolization (Drug Eluting Bead Transarterial Chemoembolization) — Memorial Sloan Kettering Cancer Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Drug Eluting Bead Transarterial Chemoembolization TARGET | Drug Eluting Bead Transarterial Chemoembolization | Memorial Sloan Kettering Cancer Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Drug Eluting Bead Transarterial Chemoembolization CI watch — RSS
- Drug Eluting Bead Transarterial Chemoembolization CI watch — Atom
- Drug Eluting Bead Transarterial Chemoembolization CI watch — JSON
- Drug Eluting Bead Transarterial Chemoembolization alone — RSS
Cite this brief
Drug Landscape (2026). Drug Eluting Bead Transarterial Chemoembolization — Competitive Intelligence Brief. https://druglandscape.com/ci/drug-eluting-bead-transarterial-chemoembolization. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab